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Advanced Therapy of Breast Disease ‘is designed to
provide a concise, current, and comprehensive survey of
advanced concepts in the management of both benign
and malignant disease of the breast. It is not intended to
be a comprehensive review, but rather a unique collection
of expert opinions…’. These are the aims set forth in the
preface and I must say that the book does exactly what it
says on the cover.
The book provides a flavour of the change that is
occurring in approaches to breast cancer management,
from ‘kill to cure’ to prevention and long-term management
as a chronic disease. The contributors and the chapter
topics have been chosen carefully, although I would have
liked a chapter dedicated to the natural history of breast
cancer. In keeping with the title, though, there are sections
dedicated to the therapy of almost every aspect of breast
disease.
The evaluation and treatment of benign breast diseases
covers in detail common problems such as mastalgia.
Recent advances such as ductoscopy and percutaneous
management of fibroadenoma are touched on. The
description of high-throughput protein analysis of nipple
aspiration fluid includes a table of exciting results that
spans two pages. The level of HER2/neu in nipple
aspiration fluid can be as much as 50 times the
concurrent serum level. Comparing the expression profiles
in the two breasts of a patient with unilateral cancer allows
an excellent control for the identification of useful markers
for the prevention and treatment of breast cancer in
general, and nipple discharge in particular.
The quantitative assessment of genetic risk of breast
cancer and the various aspects of its management – from
counselling to bilateral prophylactic mastectomy – is well
covered. The epidemiological and psychological aspects
as well as important surgical nuances are mentioned. For
example, the photos of the double opposing tab flap
nipple reconstruction are very instructive.
There is a chapter on screening mammography, although
with nominal regard to recently publicised doubts about
its true efficacy. This is not the place to argue about it, but
it is a shame that only one side of the argument is
included. Irrespective of whether screening with
mammography is beneficial or harmful, it seems that it is
here to stay and we can only inform women about its fine
balance between benefit and harm. Breast self
examination has a chapter dedicated to it, if only to fare a
polite goodbye.
The book includes a chapter on the latest version of the
TNM/AJCC staging. In practice the use of detailed TNM
staging mainly enables an audit of cases rather than the
planning of appropriate treatment. For the latter purpose
many other factors come into play. These are discussed in
detail in individual chapters on chemotherapy and
hormonal agents. In this computer age, software such as
Adjuvant! (www.adjuvantonline.com) can offer a
quantitative basis for decisions about adjuvant therapy
rather than only the subjective ‘feel’ that is provided by the
other prognostic indices. I was surprised that this is
mentioned only in the chapter ‘Breast cancer in older
women’ in the ‘Special presentations’ section. Perhaps in
the next edition the current popularity of this method will be
reflected and it will be covered in more detail in the main
adjuvant therapy section.
There is a chapter on preoperative systemic therapy that
discusses the role of chemotherapy before operation, but
there is no mention of preoperative hormone therapy,
which is rapidly gaining popularity and is even more
relevant as there are increasing numbers of older women
with breast cancer who are more likely to be dependent
on oestrogen. It is mentioned only as a small paragraph in
the chapter ‘Feasibility of breast conservation therapy’.
A chapter explains very well the importance of
radiotherapy in local treatment of early-stage breast
cancer and briefly mentions partial breast irradiation. This
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particular chapter was perhaps written before the
intraoperative radiotherapy trials such as ELIOT and
TARGIT were initiated in the year 2000.
Management of locally advanced breast cancer and of
systemic disease is dealt with in separate sections, with
chapters dedicated to individual issues such as bone
metastases and brain metastases. A section describes
special cases that, in addition to the usual, include cancer
in the augmented breast or recurrence in a reconstructed
breast.
Follow-up care is discussed in a large section, and
reiterates in a clear chapter how intensive follow-up does
not serve any purpose: ‘It seems clear that patients want
to be seen and evaluated by their physician (although this
may not be true for English patients, as opposed to
American), but bone scans, chest roentgenograms, and
serum chemistry determinations are not medically
necessary, do not improve survival, and may decrease
quality of life.’
The section on future directions gives a small glimpse of
the future, with chapters such as molecular targeted
therapy and molecular profiling.
There is an accompanying CD that I found very useful. The
CD is easy to navigate and chapters are arranged in PDF
file format. However, there is no facility to search across
the whole book, unless one creates a PDF catalogue with
Adobe Acrobat. Such a facility (a ‘search the book’
button) could be perhaps included in the next edition.
Flicking through the book I found that it was easy to find
something of interest throughout the book. For example,
one would notice something that one had recently heard
about and then find an in-depth analysis about it in the
chapter, although sometimes this was not completely
balanced. On the whole this book would be a useful
addition to the desk of a busy surgeon or oncologist who
wishes to freshen up his or her understanding of breast
diseases.
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